Company Revenue

The company grew in the double digits for 3Q21, aided by strong international sales in European and South American markets....

The company grew nearly 36% in FY 2Q21 as its domestic Japanese and international markets rebounded from pandemic lows in...

The company's 3Q21 sales fell in the high single digits due to the dual headwinds of COVID and OUS trauma...

The company grew almost 24% in 3Q21 due in large part to order timing from its strategic viscosupplement sales partners,...

The company grew in the mid-single digits for 3Q21 despite orthopedic surgery delays and a strong comparison in the prior...

The company grew more than 50% in the third quarter of 2021, driven in part by an $11 million contribution...

The company's orthopedic sales grew in the low single digits for 3Q21 amid a commercial reorganization meant to better leverage...

The company grew in the low single-digits for 3Q21 as its spine and international businesses offset COVID declines in the...

The company's 3Q21 orthopedic sales declined -0.5% due to procedure delays, staffing shortages and larger-than-expected impact from China....

The company's sales declined in the low double digits in 3Q21 due to procedure delays, with relief likely at some...